Ocugen Inc (OCGN) concluded trading on Thursday at a closing price of $0.71, with 5.25 million shares of worth about $3.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.71% during that period and on May 15, 2025 the price saw a gain of about 2.12%. Currently the company’s common shares owned by public are about 292.03M shares, out of which, 286.01M shares are available for trading.
Stock saw a price change of 2.89% in past 5 days and over the past one month there was a price change of 1.50%. Year-to-date (YTD), OCGN shares are showing a performance of -11.89% which decreased to -60.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $2.06 during that period. The average intraday trading volume for Ocugen Inc shares is 3.71 million. The stock is currently trading -0.14% below its 20-day simple moving average (SMA20), while that difference is up 6.53% for SMA50 and it goes to -19.26% lower than SMA200.
Ocugen Inc (NASDAQ: OCGN) currently have 292.03M outstanding shares and institutions hold larger chunk of about 25.68% of that.
The stock has a current market capitalization of $207.13M and its 3Y-monthly beta is at 4.16. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 2.60 while making debt-to-equity ratio of 2.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OCGN, volatility over the week remained 8.61% while standing at 7.17% over the month.
Analysts are in expectations that Ocugen Inc (OCGN) stock would likely to be making an EPS of -0.06 in the current quarter, while forecast for next quarter EPS is -0.06 and it is -0.25 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.06 which is -0.05 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.04 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -15.00% while it is estimated to decrease by -4.35% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on October 15, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. Coverage by Chardan Capital Markets stated Ocugen Inc (OCGN) stock as a Buy in their note to investors on March 01, 2023, suggesting a price target of $3.50 for the stock. On August 23, 2022, Mizuho Initiated their recommendations, while on June 15, 2022, ROTH Capital Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Cantor Fitzgerald on June 02, 2022.
